priligy fda approval cdk1 and cdk2 mediated phosphorylation of MyoD Ser200 in growing C2 myoblasts role in modulating MyoD half life and myogenic activity
priligy fda approval cdk1 and cdk2 mediated phosphorylation of MyoD Ser200 in growing C2 myoblasts role in modulating MyoD half life and myogenic activity